Investor Relations

2014 Press Releases

Webcast ImageWebcast
Q4 2016 Lantheus Holdings, Inc. Earnings Conference Call (Replay)
02/21/17 at 4:30 p.m. ET
Q4 2016 Lantheus Holdings, Inc. Earnings Conference Call
Tuesday, February 21, 2017 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
2017 | 2016 | 2015 | 2014 | 2013 | 2012
DateTitle 
11/12/14Lantheus Medical Imaging Reports Third Quarter 2014 Financial Results
... 
11/05/14Lantheus to Host Third Quarter 2014 Earnings Conference Call on November 12, 2014 at 4:30 p.m. Eastern Time
N. Billerica, Mass., November 5, 2014 – Lantheus Medical Imaging, Inc. (Lantheus) today announced that it will host a conference call at 4:30 p.m. ET on Wednesday, November 12, 2014, to discuss its financial and operating results for the third quarter of 2014. To access the live conference call via telephone, please dial 1-877-299-4454 (U.S. callers) or 1‑617-597-5447 (international callers) and provide passcode 59235085. A live audio webcast of the call also will be available on the hom... 
11/03/14Lantheus Medical Imaging and SHINE Medical Announce Mo-99 Supply Agreement
Agreement Supports U.S. Efforts to Ensure Future Reliable Supply of Non-HEU Mo-99 N. BILLERICA, Mass. (November 3, 2014) – Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing, selling and distributing innovative diagnostic imaging agents, and SHINE Medical Technologies, Inc., a Wisconsin-based company dedicated to being the world leader in safe, clean, affordable production of medical isotopes, today announced that the companies have entered into a strategic a... 
09/18/14Lantheus Medical Imaging to Present Data on Novel PET Cardiac Imaging Agent Flurpiridaz F 18 at ASNC Annual Scientific Session
N. BILLERICA, Mass. (September 18, 2014) – Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing, selling and distributing innovative diagnostic imaging agents, today announced that data demonstrating significant reductions in radiation exposure and improved image quality with flurpiridaz F 18 myocardial perfusion imaging (MPI) as compared with single photon emission computed tomography (SPECT) will be presented in a poster presentation at the American Society of Nuclear C... 
09/10/14Lantheus Medical Imaging to Present at Imperial Capital Global Opportunities Conference on September 18, 2014
N. Billerica, Mass., September 10, 2014 – Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing, selling and distributing innovative diagnostic imaging agents, today announced that it will be participating in the Imperial Capital Global Opportunities Conference on Thursday, September 18, 2014 in New York City. Jeff Bailey, President and Chief Executive Officer, will present at 9:30 a.m., Eastern Time. To access a live webcast of the presentation, please visit th... 
08/12/14Lantheus Medical Imaging Reports Results for Second Quarter Ended June 30, 2014
... 
08/05/14Lantheus to Host Second Quarter 2014 Conference Call on August 12, 2014 at 4:30 p.m. Eastern Time
N. Billerica, Mass., August 5, 2014 – Lantheus Medical Imaging, Inc. (Lantheus) today announced that it will host a conference call at 4:30 p.m. ET on Tuesday, August 12, 2014, to discuss its financial and operating results for the second quarter of 2014. To access the live conference call via telephone, please dial 1-866-510-0712 (U.S. callers) or 1‑617-597-5380 (international callers) and provide passcode 37835042. A live audio webcast of the call also will be available on the homepage... 
06/24/14Lantheus Holdings, Inc. Announces Filing of Registration Statement for Proposed Initial Public Offering
No. BILLERICA, Mass. (June 24, 2014) – Lantheus Holdings, Inc. (“Lantheus Holdings” or the “Company”), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in developing, manufacturing, selling and distributing innovative diagnostic imaging agents, announced today that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to a proposed initial public offering of its common stock. Lantheus Holdings intends to apply to... 
06/02/14Lantheus Medical Imaging Announces appointment of John K. Bakewell as New Chief financial Officer
No. BILLERICA, Mass. (June 2, 2014) – Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, announced the appointment of John K. Bakewell as the Company’s new Chief Financial Officer, effective today. Mr. Bakewell replaces John Golubieski, who served as interim Chief Financial Officer since July 2013. Mr. Golubieski will work with Lantheus for an interim period to ensure a smooth transition. Mr. Bakewell brin... 
05/01/14Lantheus to Host First Quarter 2014 Conference Call on May 6, 2014 at 3:00 p.m. Eastern Time
N. Billerica, Mass., May 1, 2014 – Lantheus Medical Imaging, Inc. (Lantheus) today announced that it will host a conference call at 3:00 p.m. ET on Tuesday, May 6, 2014, to discuss its financial and operating results for the first quarter of 2014. To access the live conference call via telephone, please dial 1-877-415-3178 (U.S. callers) or 1‑857-244-7321 (international callers) and provide passcode 51271598. A live audio webcast of the call also will be available on the homepage of the Co... 
03/10/14Lantheus to Host Fourth Quarter and Full Year 2013 Conference Call on March 12, 2014 at 3:00 p.m. Eastern Time
N. Billerica, Mass., March 10, 2014 –Lantheus Medical Imaging, Inc. (Lantheus) today announced that it will host a conference call at 3:00 p.m. ET on Wednesday, March 12, 2014, to discuss its financial and operating results for the fourth quarter and full year of 2013. To access the live conference call via telephone, please dial 1-866-202-0886 (U.S. callers) or 1-617-213-8841 (international callers) and provide passcode 51663240. A live audio webcast of the call also will be available on the ... 
02/20/14Lantheus Medical Imaging to Present at the RBC Capital Healthcare Conference on February 26, 2014
FOR IMMEDIATE RELEASE CONTACTS:     Linda Lennox   Meara Murphy 978-671-8854   978-671-8508   Lantheus Medical Imaging to Present at the RBC Capital Markets’ Healthcare Conference on February 26, 2014 N. Billerica, Mass., February 20, 2014 – Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that Jeff Bailey, President and Chief Executiv...